Minimum Appropriate Follow-Up Reduces Mortality After Endoprosthesis Implantation

No study has been able to prove long-term benefit of regular imaging follow-up after abdominal aortic aneurysm repair by means of endoprosthesis implantation. This is important because the costs for these studies are high, which should be added to potential radiation and contrast morbidity.

Un seguimiento mínimo y apropiado reduce la mortalidad luego de una endoprótesis

This work sought to characterize the association between post-endovascular abdominal aortic aneurysm repair imaging frequency and long-term survival.

 

Minimum appropriate imaging follow-up was defined as a computerized tomography (CT) scan or ultrasound of the abdomen within 90 days of the procedure, as well as every 15 months thereafter. A multivariate analysis was conducted to determine the association between compliance with minimum appropriate imaging follow-up over time and all-cause mortality.


Read also: Polymer-Free DES Also Show Efficacy in Anticoagulated Patients with High Risk for Bleeding”.


The study enrolled 4988 patients treated with an endoprosthesis, and the mean follow-up was 3.4 years. Ninety-day mortality was 1.6%. Among those who survived over 90 days, 87% (n = 4251 of 4902) underwent at least one CT scan or ultrasound of the abdomen within 3 months, but only 58% (n = 2859 of 4902) came back afterwards to meet minimum appropriate imaging follow-up criteria.

 

Infrequent imaging correlated with lower follow-up by an interventional cardiologist or the vascular surgeon who performed the implantation, but not with infrequent primary care. Patients continued visiting their primary care physician, who did not refer them to specialists in a timely manner for minimum appropriate follow-up for their abdominal aortic aneurysm.

 

Consistently meeting minimum appropriate follow-up criteria was associated with a lower mortality rate when compared with patients who did not undergo a scan within 90 days (hazard ratio [HR]: 0.82; 95% confidence interval [CI]: 0.69-0.96; p = 0.014), or when compared with patients who underwent a first imaging follow-up within 90 days but missed subsequent follow-up instances (HR: 0.78; 95% CI: 0.68-0.91; p = 0.001).


Read also: Pacemaker Implantation After TAVI Raises Costs But Not the Incidence of Adverse Events”.


The longer the patients remained within the minimum appropriate follow-up protocol, the lower the mortality rates.

 

Conclusion

These data support efforts to improve long term follow-up of patients who receive an endoprosthesis during infrarenal aortic aneurysm repair.

 

Editorial

The lower mortality rates observed with regular follow-up after prosthesis implantation can be partially explained by imaging studies. Imaging follow-up may actually be a subrogated endpoint, and reduced mortality may be a consequence of, for example, better control of cardiovascular risk factors, or a change in lifestyle after the procedure.

 

Patients who disregarded the follow-up still visited their primary care physician regularly, which means that there is an opportunity to improve communication with these physicians in order to obtain adequate imaging follow-up.

 

Original title: The Impact of Compliance with Imaging Follow-up on Mortality After Endovascular Abdominal Aortic Aneurysm Repair: A Population Based Cohort Study.

Reference: C. de Mestral et al. Eur J Vasc Endovasc Surg (2017). Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...

IVUS-Guided vs. Angiography-Guided Drug-Coated Balloon Angioplasty in the Treatment of Femoropopliteal Lesions

Angiography has traditionally been the primary imaging technique for endovascular therapy guidance in patients with peripheral artery disease. However, as it only provides two-dimensional...

New Carotid PCI All-in-One System

Carotid stenting is equivalent to carotid endarterectomy in terms of major adverse events (death, AMI, and stroke). However, it entails higher risk of minor...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...